MetaCap

Intercure Ltd. Company Profile

NASDAQ: INCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.03-0.10 (-1.95%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Intercure at a glance

Intercure Ltd. (NASDAQ: INCR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Herzliya, Israel. Intercure is led by Mr. Alexander Rabinovich and employs about 285 people. At a market capitalization of $77.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001857030, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Intercure do?

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Business description based on the company's public filings.

Company information

Legal name
Intercure Ltd.
Ticker
NASDAQ: INCR
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Alexander Rabinovich
Employees
285
Headquarters
85 Medinat ha-Yehudim Street, Herzliya, Israel
Phone
972 7 746 05012
Market cap
$76.97M
SEC CIK
0001857030

Companies similar to Intercure

INCR peer companies
CompanyPrice% ChgMarket capCompare
RFLRafael Holdings Inc. Class B1.480.00%$76.96Mvs INCR
OSTXOS Therapies Incorporated1.62+4.52%$75.82Mvs INCR
MNOVMedicinova Inc1.54-4.35%$75.80Mvs INCR
LFVNLifevantage Corporation5.99-0.17%$75.41Mvs INCR
PDSBPDS Biotechnology Corporation1.02-4.23%$73.92Mvs INCR
ACRVAcrivon Therapeutics Inc.1.87-0.53%$80.14Mvs INCR
NTHINeOnc Technologies Holdings Inc.2.53-6.64%$72.88Mvs INCR
PMNProMIS Neurosciences Inc.9.15+0.33%$82.05Mvs INCR

Related